Ovintiv director corrects NuVista share allocation

Ovintiv Inc. director files amended Form 4 to correct share amount received in a prior transaction.

Rhea-AI Filing Summary

Ovintiv Inc. director files amended Form 4 to correct share amount received in a prior transaction. The reporting person now reports acquiring 19,742 shares of Ovintiv common stock on February 3, 2026 in connection with the NuVista plan of arrangement, at a price of $38.27 per share.

The earlier filing had shown 34,160 shares for this transaction, and this amendment states that 19,742 is the correct figure after final verification. Following the corrected transaction, the director beneficially owns 63,051 Ovintiv common shares directly.

Insider Trade Summary

Other: 19,742 shares

Other 1 txn

Insider Shaw Brian Gordon

Role Director

Type	Security	Shares	Price	Value
Other	Common Stock	19,742	$38.27	$756K

Holdings After Transaction: Common Stock — 63,051 shares (Direct)

Footnotes (1)

1. F1. This amendment revises the Form 4 filed on February 5, 2026. The reporting person previously reported receiving 34,160 Ovintiv Inc. shares in connection with the NuVista plan of arrangement dated effective February 3, 2026. Upon final verification, the correct amount is 19,742 shares. The holdings reported herein have been updated accordingly.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Ovintiv (OVV) amended Form 4 filed on February 9, 2026 report?

The amended Form 4 corrects a prior insider report for an Ovintiv director. It states the director actually received 19,742 Ovintiv common shares on February 3, 2026 under the NuVista plan of arrangement, instead of the 34,160 shares previously reported, and updates holdings accordingly.

How many Ovintiv (OVV) shares did the director acquire in the corrected transaction?

The director is reported to have acquired 19,742 Ovintiv common shares on February 3, 2026. This was part of consideration received under the NuVista plan of arrangement, revising the originally reported amount of 34,160 shares after final verification of the correct share allocation.

What is the director’s total Ovintiv (OVV) share ownership after this amended Form 4?

After the correction, the director beneficially owns 63,051 Ovintiv common shares on a direct basis. This total reflects the updated 19,742 shares received in the NuVista plan of arrangement, replacing the previously overstated 34,160-share figure in the earlier Form 4 filing.

What transaction price is reported in the Ovintiv (OVV) Form 4/A amendment?

The corrected transaction lists a price of $38.27 per share for the 19,742 Ovintiv common shares. This price is associated with the February 3, 2026 acquisition tied to the NuVista plan of arrangement, as disclosed in the amended insider ownership report for the director.

Why was the Ovintiv (OVV) insider filing from February 5, 2026 amended?

The earlier insider report was amended because it overstated the shares received in the NuVista plan of arrangement. It originally showed 34,160 Ovintiv shares, but after final verification, the correct amount was determined to be 19,742 shares, requiring an updated Form 4/A.

What role does the reporting person hold at Ovintiv (OVV) in this Form 4/A?

The reporting person is identified as a director of Ovintiv Inc. The Form 4/A indicates the filing is made by one reporting person, who directly owns the updated 63,051 Ovintiv common shares following correction of the NuVista-related share acquisition entry.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/09/2026 - 05:43 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shaw Brian Gordon

(Last) (First) (Middle)

C/O 370 17TH STREET, SUITE 1700

(Street)

DENVER CO 80202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ovintiv Inc. [ OVV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)
02/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/03/2026		J		19,742(1)	A	$38.27	63,051	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This amendment revises the Form 4 filed on February 5, 2026. The reporting person previously reported receiving 34,160 Ovintiv Inc. shares in connection with the NuVista plan of arrangement dated effective February 3, 2026. Upon final verification, the correct amount is 19,742 shares. The holdings reported herein have been updated accordingly.

	/s/Dawna Gibb, by Power of Attorney	02/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.